Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
Pool Corporation to Present at the Oppenheimer 20th Annual Industrial Growth Conference
Market Updates

Pool Corporation to Present at the Oppenheimer 20th Annual Industrial Growth Conference

COVINGTON, La., April 28, 2025 (GLOBE NEWSWIRE) -- Pool Corporation (Nasdaq:POOL) announced today that Melanie M. Hart, Senior Vice President and Chief Financial Officer, will participate in the Oppen...

  • April 28, 2025 01:05 PM PDT
  • EODHD
Tempest Presents New Amezalpat MOA Data Reinforcing Its Potential as Novel Cancer Treatment at the 2025 AACR Annual Meeting
Market Updates

Tempest Presents New Amezalpat MOA Data Reinforcing Its Potential as Novel Cancer Treatment at the 2025 AACR Annual Meeting

BRISBANE, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeut...

  • April 28, 2025 01:05 PM PDT
  • EODHD
LifeMD to Report First Quarter 2025 Financial Results on May 6
Market Updates

LifeMD to Report First Quarter 2025 Financial Results on May 6

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ende...

  • April 28, 2025 01:05 PM PDT
  • EODHD
Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025
Market Updates

Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025

SOUTH SAN FRANCISCO, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug...

  • April 28, 2025 01:05 PM PDT
  • EODHD
CORCEPT THERAPEUTICS TO ANNOUNCE FIRST QUARTER FINANCIAL RESULTS, PROVIDE CORPORATE UPDATE AND HOST CONFERENCE CALL
Market Updates

CORCEPT THERAPEUTICS TO ANNOUNCE FIRST QUARTER FINANCIAL RESULTS, PROVIDE CORPORATE UPDATE AND HOST CONFERENCE CALL

REDWOOD CITY, Calif., April 28, 2025--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report first quarter financial results and provide a corporate update on...

  • April 28, 2025 01:05 PM PDT
  • EODHD
Solésence To Report First Quarter 2025 Financial Results and Host a Conference Call
Market Updates

Solésence To Report First Quarter 2025 Financial Results and Host a Conference Call

ROMEOVILLE, Ill., April 28, 2025 (GLOBE NEWSWIRE) -- Romeoville, Ill., April 28, 2025 – Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life s...

  • April 28, 2025 01:01 PM PDT
  • EODHD
Bicara Therapeutics Highlights Broad Potential of Ficerafusp Alfa at AACR Annual Meeting 2025
Market Updates

Bicara Therapeutics Highlights Broad Potential of Ficerafusp Alfa at AACR Annual Meeting 2025

BOSTON, April 28, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients w...

  • April 28, 2025 01:01 PM PDT
  • EODHD
AMGEN ANNOUNCES WEBCAST OF 2025 FIRST QUARTER FINANCIAL RESULTS
Market Updates

AMGEN ANNOUNCES WEBCAST OF 2025 FIRST QUARTER FINANCIAL RESULTS

THOUSAND OAKS, Calif., April 28, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its first quarter 2025 financial results on Thursday, May 1, 2025, after the close of the...

  • April 28, 2025 01:01 PM PDT
  • EODHD
Honoring Monroe’s Birthday: New Study Highlights His Drafting Of America’s First Organic Territorial Law
Market Updates

Honoring Monroe’s Birthday: New Study Highlights His Drafting Of America’s First Organic Territorial Law

COLONIAL BEACH, Va., April 28, 2025 (SEND2PRESS NEWSWIRE) -- The James Monroe Memorial Foundation proudly announces the publication of "United States in Congress Assembled Delegate James Monroe: Archi...

Nurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel Drugs
Market Updates

Nurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel Drugs

Nurix’s DEL-AI platform uses a first-in-class DEL Foundation Model trained on the Company’s proprietary DNA encoded library data Nurix’s DEL Foundation Model can accurately predict novel binders to th...

  • April 28, 2025 01:00 PM PDT
  • EODHD